Bacteriophage-Insensitive Mutants of Antimicrobial-Resistant Salmonella Enterica are Altered in their Tetracycline Resistance and Virulence in Caco-2 Intestinal Cells
- PMID: 32164202
- PMCID: PMC7084636
- DOI: 10.3390/ijms21051883
Bacteriophage-Insensitive Mutants of Antimicrobial-Resistant Salmonella Enterica are Altered in their Tetracycline Resistance and Virulence in Caco-2 Intestinal Cells
Abstract
Bacteriophages have shown promise as therapeutic alternatives to antibiotics for the control of infectious bacteria, including the human pathogen Salmonella. However, the development of effective phage-based applications requires the elucidation of key interactions between phages and target hosts, particularly since host resistance to phage is inevitable. Little is known about the alteration of host phenotypes following the development of resistance to phage. The aim of this study is to evaluate the antibiotic susceptibility and virulence of a Salmonella isolate following the development of resistance to bacteriophage SI1. We observed enhanced susceptibility to tetracycline and decreased invasion capacity in a differentiated Caco-2 intestinal cell line. Whole genome sequence analysis revealed an array of mutations, most notably, truncations in vgrG1_2, a core gene involved in Type VI secretion and mutations in the lipopolysaccharide, thereby indicating the plausible attachment site of phage SI1. These findings shed light on understanding the underlying mechanism for phage immunity within the host. Importantly, we reveal an associated genetic cost to the bacterial host with developing resistance to phages. Taken together, these results will aid in advancing strategies to delay or eliminate the development of host resistance when designing informed phage-based antimicrobials.
Keywords: Salmonella; antibiotic resistance; phage resistance; virulence.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Fitness Trade-Offs in Phage Cocktail-Resistant Salmonella enterica Serovar Enteritidis Results in Increased Antibiotic Susceptibility and Reduced Virulence.Microbiol Spectr. 2022 Oct 26;10(5):e0291422. doi: 10.1128/spectrum.02914-22. Epub 2022 Sep 27. Microbiol Spectr. 2022. PMID: 36165776 Free PMC article.
-
Collateral sensitivity increases the efficacy of a rationally designed bacteriophage combination to control Salmonella enterica.J Virol. 2024 Mar 19;98(3):e0147623. doi: 10.1128/jvi.01476-23. Epub 2024 Feb 20. J Virol. 2024. PMID: 38376991 Free PMC article.
-
Epigenetic Control of Salmonella enterica O-Antigen Chain Length: A Tradeoff between Virulence and Bacteriophage Resistance.PLoS Genet. 2015 Nov 19;11(11):e1005667. doi: 10.1371/journal.pgen.1005667. eCollection 2015 Nov. PLoS Genet. 2015. PMID: 26583926 Free PMC article.
-
Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies.Infect Immun. 2020 Jun 22;88(7):e00926-19. doi: 10.1128/IAI.00926-19. Print 2020 Jun 22. Infect Immun. 2020. PMID: 32094257 Free PMC article. Review.
-
Salmonella pathogenicity islands in host specificity, host pathogen-interactions and antibiotics resistance of Salmonella enterica.Berl Munch Tierarztl Wochenschr. 2007 Jul-Aug;120(7-8):317-27. Berl Munch Tierarztl Wochenschr. 2007. PMID: 17715824 Review.
Cited by
-
Resistance, mechanism, and fitness cost of specific bacteriophages for Pseudomonas aeruginosa.mSphere. 2024 Feb 28;9(2):e0055323. doi: 10.1128/msphere.00553-23. Epub 2024 Feb 1. mSphere. 2024. PMID: 38299825 Free PMC article.
-
Bypassing Evolution of Bacterial Resistance to Phages: The Example of Hyper-Aggressive Phage 0524phi7-1.Int J Mol Sci. 2025 Mar 23;26(7):2914. doi: 10.3390/ijms26072914. Int J Mol Sci. 2025. PMID: 40243527 Free PMC article.
-
Effect of phage vB_EcoM_FJ1 on the reduction of ETEC O9:H9 infection in a neonatal pig cell line.Vet Res. 2023 Mar 22;54(1):26. doi: 10.1186/s13567-023-01157-x. Vet Res. 2023. PMID: 36949480 Free PMC article.
-
Phage Therapy-Challenges, Opportunities and Future Prospects.Pharmaceuticals (Basel). 2023 Nov 22;16(12):1638. doi: 10.3390/ph16121638. Pharmaceuticals (Basel). 2023. PMID: 38139765 Free PMC article. Review.
-
Non-antibiotic therapies for multidrug-resistant gastrointestinal infections: an overview of the use of probiotics, natural compounds, and bacteriophages.Front Antibiot. 2025 May 6;4:1554061. doi: 10.3389/frabi.2025.1554061. eCollection 2025. Front Antibiot. 2025. PMID: 40395696 Free PMC article. Review.
References
-
- Majowicz S., Musto J., Scallan E., Angulo F., Kirk M., O’Brien S.J., Jones T.F., Fazil A., Hoekstra R.M. International Collaboration on Enteric Disease ‘Burden of Illness’ Studies. The global burden of nontyphoidal Salmonella gastroenteritis. Clin. Infect. Dis. 2010;50:882–889. doi: 10.1086/650733. - DOI - PubMed
-
- Reports of Selected Salmonella Outbreak Investigations. [(accessed on 30 August 2019)]; Available online: https://www.cdc.gov/salmonella/outbreaks.html.
-
- Fong K., LaBossiere B., Switt A.I.M., Delaquis P., Goodridge L., Levesque R.C., Danyluk M.D., Wang S. Characterization of four novel bacteriophages isolated from British Columbia for control of non-typhoidal Salmonella in vitro and on sprouting alfalfa seeds. Front. Microbiol. 2017;8:2193. doi: 10.3389/fmicb.2017.02193. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources